IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

DSM's net profit falls 13% in the first quarter as performance materials sales decline

5:16 AM MDT | May 2, 2013 | Francinia Protti-Alvarez

DSM's core net profit fell 13.4%, to €129 million ($170 million) during the first quarter of 2013, compared with the same period last year when it stood at €149 million, the company announced today. Ebitda, meanwhile, rose by 1.6% from €306 million during the first quarter of 2012, to €311 million in the latest reporting period. Net sales also increased by about 4%, to €2.38 billion during the first quarter of 2013, from €2.29 billion in the same period the year before. Life sciences delivered the company's growth once again, driven...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa